Abstract :
Dear Editor, I read with great interest the study of Korkmaz et al. entitled ‘Epicardial adipose tissue increased in patients with newly diagnosed subclinical hypothyroidism . The authors investigated the relationship between epicardial fat tissue thickness and subclinical hypothyroidism and reported that the epicardial fat tissue thickness was greater in patients with subclinical hypothyroidism than in control subjects. This cross-sectional study is noteworthy because of its interest and potential usefulness in clinical practice. However, I would like to comment on two points. Firstly, authors calculated the epicardial fat tissue thickness using an echocardiographic technique. Although several studies have been conducted with this technique, echocardiography measurement is not the gold standard for calculating epicardial tissue thickness. Epicardial adipose tissue thickness is most precisely quantified by MRI or CT imaging, and thickness of epicardial fat in the atrioventricular groove has been shown to provide a more accurate assessment of its atherogenic risk. I think that this should have been stated as a limitation. Secondly, there are studies that show the relationship between epicardial fat tissue thickness and metabolic syndrome. I think that the authors should have included this relationship in the Discussion section, this would have added more value to the results of their study.
